Startups
We are a leading player in the peripheral and neurovascular interventional medical device market in China. As a fully integrated medical device company, we have strong R&D and manufacturing capabilities, multiple specialized technology platforms, and proven commercialization capabilities. Led by our talented management team, we strive to provide the best medical services and cutting-edge technical solutions to physicians and patients in China and around the world. We are an integrated solution provider, offering the most comprehensive product solutions for peripheral and neurovascular medical devices in China. Since the establishment in 2012, we have systematically developed more than 40 quality products to adequately cover the rapidly growing neurovascular and peripheral vascular intervention market.
Overview
Location
China, Zhejiang, Yuhang District
Employees
201-500
Founded date
2012
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 18
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 18, 2026 | Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year | HANGZHOU, China, March 18, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company") today announced its annual results for the year ended December 31, 2025. In 20... |
| Jan 16, 2026 | Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market | Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide Delivers Zylox-... |
| Jan 12, 2026 | Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy | HANGZHOU, China, Jan. 12, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Investor Open Day at its Zhuhai Inno... |
| Mar 22, 2024 | Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability | HANGZHOU, China, March 22, 2024 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announced its annual financial res... |
| Mar 7, 2024 | Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions | HANGZHOU, China, March 7, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China, today announced a new strategic partners... |
| Feb 21, 2024 | Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE | HANGZHOU, China, Feb. 20, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Healt... |
| Nov 13, 2023 | Aspira Catheter Instructions | Aspira Catheter Instructions What Is An Aspiration Catheter? The Cylone™ Aspiration Catheter is intended for use in the removal/aspiration of emboli and thrombi from selected blood vessels in the arterial system including the peripheral and... |
| Nov 13, 2023 | Peripheral Vascular Treatment | Peripheral Vascular Treatment What Is Peripheral Vascular Disease? Peripheral Vascular Disease (PVD) refers to conditions that affect blood vessels outside the heart and cerebral arteries. It is commonly caused by atherosclerosis, blood clo... |
| Sep 18, 2023 | Zylox-Tonbridge was Added to the FTSE Global Equity Index Series | HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total... |
Show more
Reviews 0
FAQ about Zylox & Tonbridge
When was Zylox & Tonbridge founded?
Zylox & Tonbridge was founded in 2012.
What has the press written about Zylox & Tonbridge?
Parsers VC has collected 18 articles mentioning Zylox & Tonbridge, among them “Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year” (Mar 18, 2026) and “Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market” (Jan 16, 2026).
Is Zylox & Tonbridge still active?
Zylox & Tonbridge is probably closed: its latest activity on Parsers VC dates from Jun 8, 2026.